Adaptimmune Therapeutics PLC ADR buy BiotechBee
Start price
04.02.24
/
60%
€0.98
Target price
31.10.25
€1.50
Performance (%)
2.04%
Price
26.04.24
€1.00
Summary
This prediction is currently active. The BUY prediction by BiotechBee shows slight gains of 2.04%. This prediction currently runs until 31.10.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Adaptimmune Therapeutics PLC ADR | 9.290% | 9.290% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
According to BiotechBee what are the pros and cons of Adaptimmune Therapeutics PLC ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Adaptimmune Therapeutics PLC ADR diskutieren
Buy mit Kursziel 1,5